| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892 [T. M., W. M., A. R. C., H. F., S. T. H.], and Department of Dermatology, University of Zürich Medical School, Zürich CH-8091, Switzerland [A. T. K., F. O. N.]
The chemokine receptors CC chemokine receptor (CCR) 7 and CXC chemokine receptor (CXCR) 4 have been implicated in cancer metastasis. To evaluate whether CXCR4 is sufficient to increase tumor metastasis in an organ-specific manner, we transduced murine B16 melanoma cells with CXCR4 (CXCR4-B16) and followed the metastatic fate of the transduced cells in both i.v. and s.c. inoculation models of metastasis. CXCR4-B16 cells demonstrated marked increases (>10-fold) in pulmonary metastasis compared with vector (pLNCX2)-B16 after i.v. and s.c. inoculation of tumor cells. The increase in metastasis could be completely inhibited by T22, a small peptide antagonist of CXCR4. As early as 24 and 48 h after i.v. injection, CXCR4-B16 cells were significantly increased in the lung compared with control B16 cells by 5- and 10-fold (P < 0.05), respectively. CXCR4-B16 cells adhered better to both dermal and pulmonary microvascular endothelial cells relative to control B16 cells. Moreover, CXCL12 promoted the growth of CXCR4-B16 cells in vitro. Whereas expression of CXCR4 in B16 cells dramatically enhanced pulmonary metastasis, metastasis to the lymph nodes, liver, and kidney was rare. Immunohistochemical staining of both primary human cutaneous melanoma and pulmonary metastases revealed CXCR4 expression. Thus, CXCR4 plays a potentially important role in promoting organ-selective metastasis, possibly by stimulating tumor adhesion to microvascular endothelial cells and by enhancing the growth of tumor cells under stress.
This article has been cited by other articles:
|
|
 |
|
  Y. Cui, H. Zhang, J. Meadors, R. Poon, M. Guimond, and C. L. Mackall Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts Blood, October 29, 2009; 114(18): 3831 - 3840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Cabioglu, A. A. Sahin, P. Morandi, F. Meric-Bernstam, R. Islam, H. Y. Lin, C. D. Bucana, A. M. Gonzalez-Angulo, G. N. Hortobagyi, and M. Cristofanilli Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications Ann. Onc., June 1, 2009; 20(6): 1013 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Molina-Ortiz, R. A. Bartolome, P. Hernandez-Varas, G. P. Colo, and J. Teixido Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine-promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA J. Biol. Chem., May 29, 2009; 284(22): 15147 - 15157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yanagisawa, I. Kadouchi, K. Yokomori, M. Hirose, M. Hakozaki, H. Hojo, K. Maeda, E. Kobayashi, and T. Murakami Identification and Metastatic Potential of Tumor-Initiating Cells in Malignant Rhabdoid Tumor of the Kidney Clin. Cancer Res., May 1, 2009; 15(9): 3014 - 3022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ma, K. Norsworthy, N. Kundu, W. H. Rodgers, P. A. Gimotty, O. Goloubeva, M. Lipsky, Y. Li, D. Holt, and A. Fulton CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model Mol. Cancer Ther., March 1, 2009; 8(3): 490 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bartolome, S. Ferreiro, M. E. Miquilena-Colina, L. Martinez-Prats, M. L. Soto-Montenegro, D. Garcia-Bernal, J. J. Vaquero, R. Agami, R. Delgado, M. Desco, et al. The Chemokine Receptor CXCR4 and the Metalloproteinase MT1-MMP Are Mutually Required during Melanoma Metastasis to Lungs Am. J. Pathol., February 1, 2009; 174(2): 602 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Chien, E. C. Moore, A. S. Lonsdorf, R. M. Kulikauskas, B. G. Rothberg, A. J. Berger, M. B. Major, S. T. Hwang, D. L. Rimm, and R. T. Moon Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model PNAS, January 27, 2009; 106(4): 1193 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wong and W. Korz Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside Clin. Cancer Res., December 15, 2008; 14(24): 7975 - 7980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. He, L. Fang, J. Wang, Y. Yi, S. Zhang, and X. Xie Bryostatin-5 Blocks Stromal Cell-Derived Factor-1 Induced Chemotaxis via Desensitization and Down-regulation of Cell Surface CXCR4 Receptors Cancer Res., November 1, 2008; 68(21): 8678 - 8686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Bartolome, N. Wright, I. Molina-Ortiz, F. J. Sanchez-Luque, and J. Teixido Activated G{alpha}13 Impairs Cell Invasiveness through p190RhoGAP-Mediated Inhibition of RhoA Activity Cancer Res., October 15, 2008; 68(20): 8221 - 8230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Abrams, P. C. Lee, J. L. Port, N. K. Altorki, and A. I. Neugut Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2707 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-T. Tan, C.-Y. Chu, Y.-C. Lu, C.-C. Chang, B.-R. Lin, H.-H. Wu, H.-L. Liu, S.-T. Cha, E. Prakash, J.-Y. Ko, et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway Carcinogenesis, August 1, 2008; 29(8): 1519 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Witze, E. S. Litman, G. M. Argast, R. T. Moon, and N. G. Ahn Wnt5a Control of Cell Polarity and Directional Movement by Polarized Redistribution of Adhesion Receptors Science, April 18, 2008; 320(5874): 365 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. de Nigris, R. Rossiello, C. Schiano, C. Arra, S. Williams-Ignarro, A. Barbieri, A. Lanza, A. Balestrieri, M. T. Giuliano, L. J. Ignarro, et al. Deletion of Yin Yang 1 Protein in Osteosarcoma Cells on Cell Invasion and CXCR4/Angiogenesis and Metastasis Cancer Res., March 15, 2008; 68(6): 1797 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Xu, J. Sui, H. Tao, Q. Zhu, and W. A. Marasco Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Define CXCR4 Antigenic Heterogeneity J. Immunol., August 15, 2007; 179(4): 2408 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Otto, H. Starz, J. C. Becker, and D. Schrama Overexpression of Matrix Metalloproteinases, Chemokines, and Chemokine Receptors Relevant for Metastasis in Experimental Models Not an Indication of Lymph Node Metastases in Human Melanoma Arch Dermatol, July 1, 2007; 143(7): 947 - 948. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Petty, V. Sueblinvong, C. C. Lenox, C. C. Jones, G. P. Cosgrove, C. D. Cool, P. R. Rai, K. K. Brown, D. J. Weiss, M. E. Poynter, et al. Pulmonary Stromal-Derived Factor-1 Expression and Effect on Neutrophil Recruitment during Acute Lung Injury J. Immunol., June 15, 2007; 178(12): 8148 - 8157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-h. Lee, T. Kakinuma, J. Wang, H. Zhang, D. C. Palmer, N. P. Restifo, and S. T. Hwang Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Mol. Cancer Ther., October 1, 2006; 5(10): 2592 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sato, M. Ohtsuki, M. Hata, E. Kobayashi, and T. Murakami Antitumor Activity of IFN-{lambda} in Murine Tumor Models. J. Immunol., June 15, 2006; 176(12): 7686 - 7694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Andre, N. Cabioglu, H. Assi, J. C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J. P. Spano, C. Combadiere, C. Bucana, et al. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer Ann. Onc., June 1, 2006; 17(6): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Scala, P. Giuliano, P. A. Ascierto, C. Ierano, R. Franco, M. Napolitano, A. Ottaiano, M. L. Lombardi, M. Luongo, E. Simeone, et al. Human Melanoma Metastases Express Functional CXCR4 Clin. Cancer Res., April 15, 2006; 12(8): 2427 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kakinuma and S. T. Hwang Chemokines, chemokine receptors, and cancer metastasis J. Leukoc. Biol., April 1, 2006; 79(4): 639 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Bartolome, I. Molina-Ortiz, R. Samaniego, P. Sanchez-Mateos, X. R. Bustelo, and J. Teixido Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase-Dependent Melanoma Cell Invasion Cancer Res., January 1, 2006; 66(1): 248 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Kaifi, E. F. Yekebas, P. Schurr, D. Obonyo, R. Wachowiak, P. Busch, A. Heinecke, K. Pantel, and J. R. Izbicki Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer J Natl Cancer Inst, December 21, 2005; 97(24): 1840 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Burger, T. Hartmann, M. Krome, J. Rawluk, H. Tamamura, N. Fujii, T. J. Kipps, and J. A. Burger Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells Blood, September 1, 2005; 106(5): 1824 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Guleng, K. Tateishi, M. Ohta, F. Kanai, A. Jazag, H. Ijichi, Y. Tanaka, M. Washida, K. Morikane, Y. Fukushima, et al. Blockade of the Stromal Cell-Derived Factor-1/CXCR4 Axis Attenuates In vivo Tumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor-Independent Manner Cancer Res., July 1, 2005; 65(13): 5864 - 5871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hu, X. Deng, X. Bian, G. Li, Y. Tong, Y. Li, Q. Wang, R. Xin, X. He, G. Zhou, et al. The Expression of Functional Chemokine Receptor CXCR4 Is Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma Clin. Cancer Res., July 1, 2005; 11(13): 4658 - 4665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laverdiere, B. H. Hoang, R. Yang, R. Sowers, J. Qin, P. A. Meyers, A. G. Huvos, J. H. Healey, and R. Gorlick Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma Clin. Cancer Res., April 1, 2005; 11(7): 2561 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mori, J. Kim, T. Yamano, H. Takeuchi, S. Huang, N. Umetani, K. Koyanagi, and D. S.B. Hoon Epigenetic Up-regulation of C-C Chemokine Receptor 7 and C-X-C Chemokine Receptor 4 Expression in Melanoma Cells Cancer Res., March 1, 2005; 65(5): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Schimanski, S. Schwald, N. Simiantonaki, C. Jayasinghe, U. Gonner, V. Wilsberg, T. Junginger, M. R. Berger, P. R. Galle, and M. Moehler Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1743 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Scala, A. Ottaiano, P. A. Ascierto, M. Cavalli, E. Simeone, P. Giuliano, M. Napolitano, R. Franco, G. Botti, and G. Castello Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma Clin. Cancer Res., March 1, 2005; 11(5): 1835 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Perissinotto, G. Cavalloni, F. Leone, V. Fonsato, S. Mitola, G. Grignani, N. Surrenti, D. Sangiolo, F. Bussolino, W. Piacibello, et al. Involvement of Chemokine Receptor 4/Stromal Cell-Derived Factor 1 System during Osteosarcoma Tumor Progression Clin. Cancer Res., January 15, 2005; 11(2): 490 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Fraga, M. Herranz, J. Espada, E. Ballestar, M. F. Paz, S. Ropero, E. Erkek, O. Bozdogan, H. Peinado, A. Niveleau, et al. A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human Tumors Cancer Res., August 15, 2004; 64(16): 5527 - 5534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Vaday, S.-B. Hua, D. M. Peehl, M. H. Pauling, Y.-H. Lin, L. Zhu, D. M. Lawrence, H. D. Foda, and S. Zucker CXCR4 and CXCL12 (SDF-1) in Prostate Cancer: Inhibitory Effects of Human Single Chain Fv Antibodies Clin. Cancer Res., August 15, 2004; 10(16): 5630 - 5639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, T. Manabe, K. Inaba, N. Minato, M. Oshima, and M. M. Taketo Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes Cancer Res., June 1, 2004; 64(11): 4010 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Haviv, W. J. van Houdt, B. Lu, D. T. Curiel, and Z. B. Zhu Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter Mol. Cancer Ther., June 1, 2004; 3(6): 687 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Spano, F. Andre, L. Morat, L. Sabatier, B. Besse, C. Combadiere, P. Deterre, A. Martin, J. Azorin, D. Valeyre, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome Ann. Onc., April 1, 2004; 15(4): 613 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Bartolome, B. G. Galvez, N. Longo, F. Baleux, G. N. P. van Muijen, P. Sanchez-Mateos, A. G. Arroyo, and J. Teixido Stromal Cell-Derived Factor-1{alpha} Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities Cancer Res., April 1, 2004; 64(7): 2534 - 2543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yao, O. Salvucci, A. R. Cardones, S. T. Hwang, Y. Aoki, M. De La Luz Sierra, A. Sajewicz, S. Pittaluga, R. Yarchoan, and G. Tosato Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis Blood, December 1, 2003; 102(12): 3900 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murakami, A. R. Cardones, S. E. Finkelstein, N. P. Restifo, B. A. Klaunberg, F. O. Nestle, S. S. Castillo, P. A. Dennis, and S. T. Hwang Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10 J. Exp. Med., November 3, 2003; 198(9): 1337 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Cardones, T. Murakami, and S. T. Hwang CXCR4 Enhances Adhesion of B16 Tumor Cells to Endothelial Cells in Vitro and in Vivo via {beta}1 Integrin Cancer Res., October 15, 2003; 63(20): 6751 - 6757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Helbig, K. W. Christopherson II, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K. D. Miller, H. E. Broxmeyer, and H. Nakshatri NF-{kappa} B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4 J. Biol. Chem., June 6, 2003; 278(24): 21631 - 21638. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
